Zandra E. Walton - Concepedia

Author

Zandra E. Walton

Also Known As

Cameron, Michael D., Hayes, Neil D., Walton, Zandra E., Z. E. Walton, Zandra E Walton, Zandra E. Walton, Zandra Walton, Zandra E. Walton

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Harvard University Dana-Farber Cancer Institute Brigham and Women's Hospital Massachusetts General Hospital University of Pennsylvania

About

Zandra E. Walton is an author at Harvard University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	3.9K
2	Cell Biology	12	12	2.6K
3	Natural Sciences	1	1	12
4	Social Sciences	1	1	54
5	Biochemistry	1	1	216

Zandra E. Walton

Publications

Citations

H-Index

Page 1

	Year	Citations
Fructose-1,6-bisphosphatase opposes renal carcinoma progression Bo Li, Bo Qiu, David S.M. Lee, Nature Tumor BiologyUrologyGenitourinary CancerKidney ResearchRenal Pathology	2014	527
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response Chen Zhao, Katherine A. Cheng, Zandra E. Walton, Nature OncologyOncogenic AgentMedicineImmunologyTherapeutic Response	2012	447
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation Guoliang Qing, Bo Li, Annette Vu, Cancer Cell Cell RegulationApoptosisCell DeathTumor SuppressorMedicine	2012	379
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression Chunxiao Xu, Christine M. Fillmore, Shohei Koyama, Cancer Cell Tumor BiologyPten LeadsMedicinePathologyBronchial Neoplasm	2014	378
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition Neil Johnson, Yuchen Li, Zandra E. Walton, Nature Medicine Tumor BiologyParp InhibitionMedicineTumor SuppressorCancer Genetics	2011	301
MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells Brian J. Altman, Annie L. Hsieh, Arjun Sengupta, Cell Metabolism Cancer ResearchOncologyMyc DisruptsMalignant DiseaseOncogenic Agent	2015	270
Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors Julián Carretero, Takeshi Shimamura, Klarisa Rikova, Cancer Cell MedicineIntegrative GenomicCancer GenomicsBronchial NeoplasmRadiation Oncology	2010	260
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation Birgit Schoeberl, Anthony C. Faber, Danan Li, Cancer Research Ligand-dependent ActivationChemoprevention StrategyImmunologyErbb3 AntibodyCancer Biology	2010	260
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors Thomas De Raedt, Zandra E. Walton, Jessica L. Yecies, Cancer Cell Tumor BiologyCancer Cell VulnerabilitiesMedicineImmune Checkpoint InhibitorCancer Biology	2011	257
Characterization of the cell of origin for small cell lung cancer Mei‐Chih Liang, David M. Raiser, Raffaella Zamponi, Cell Cycle OncologyTumor MicroenvironmentOncogenic AgentMedicinePathology	2011	236

Page 1